Lv1
30 积分 2024-10-22 加入
Short-term outcomes of chemoradiotherapy and local excision versus total mesorectal excision in T2-T3ab,N0,M0 rectal cancer: a multicentre randomised, controlled, phase III trial (the TAU-TEM study)
1天前
待确认
Locally advanced rectal cancer with dMMR/MSI-H may be excused from surgery after neoadjuvant anti-PD-1 monotherapy: a multiple-center, cohort study
14天前
已完结
Neoadjuvant PD-1 blockade with sintilimab in mismatch-repair deficient, locally advanced rectal cancer: an open-label, single-centre phase 2 study
14天前
已完结
Anti-PD-1-based immunotherapy as curative-intent treatment in dMMR/MSI-H rectal cancer: A multicentre cohort study
14天前
已完结
Neoadjuvant Immunotherapy–Based Systemic Treatment in MMR-Deficient or MSI-High Rectal Cancer: Case Series
15天前
已完结
Neoadjuvant long‐course chemoradiation plus tislelizumab (anti-PD1) for MMR status-unscreened locally advanced rectal cancer: study protocol for a phase Ⅱ, 3‐arm, randomized trial
15天前
已完结
Adding immune checkpoint blockade to neoadjuvant chemoradiation in locally advanced rectal cancer
16天前
已关闭
Neoadjuvant Immunotherapy Leads to Major Response and Low Recurrence in Localized Mismatch Repair–Deficient Colorectal Cancer
16天前
已完结
Organ preservation after neoadjuvant long-course chemoradiotherapy versus short-course radiotherapy
20天前
已完结
Anal Carcinoma, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology
1个月前
已完结
皖公网安备34019202002308
